Achievement and Maintenance of Optimal Alignment After Adult Spinal Deformity Corrective Surgery: A 5-Year Outcome Analysis.

OBJECTIVE

We sought to assess factors contributing to optimal radiographic outcomes.

METHODS

Operative adult spinal deformity (ASD) patients with baseline and 5-year (5Y) data were included. Optimal alignment (O) was defined as improving in at least 1 Scoliosis Research Society-Schwab modifier without worsening in any Scoliosis Research Society-Schwab modifier. A robust outcome was defined as having optimal alignment 2 years (2Y) post operation that was maintained at 5Y. Predictors of robust outcomes were identified using multivariate regression analysis, with a conditional inference tree for continuous variables.

RESULTS

Two-hundred and ninety-seven ASD patients met inclusion criteria. Most patients (77.4%) met O at 6W, which decreased to 54.2% at 2Y. The majority of patients (89.4%) that met O at 2Y went on to meet radiographic durability at 5Y (48.5% of total cohort). Rates of junctional failure were higher in O2+5- compared with O2+5- (P = 0.013), with reoperation rates of 17.2% due to loss of alignment. Multivariable regression identified the following independent predictors of optimal alignment at 5Y in those that had O at 2Y: inadequate correction of pelvic tilt and overcorrection of the difference between pelvic incidence and lumbar lordosis (P < 0.05). Increased age, body mass index, and invasiveness were the most significant nonradiographic predictors for not achieving 5Y durability (P < 0.05).

CONCLUSIONS

The durability of optimal alignment after ASD corrective surgery was seen in about half of the patients at 5Y. While the majority of patients at 2Y maintained their radiographic outcomes at 5Y, major contributors to loss of alignment included junctional failure and adjacent region compensation, with only a minority of patients losing correction through the existing construct. The reoperation rate for loss of alignment was 17.2%. Loss of alignment requiring reoperation had a detrimental effect on 5Y clinical outcomes.